In response to short-term gemcitabine stress, pancreatic cancer cells accelerate invasion by up-regulating HAb18G/CD147 expression and activating HAb18G/CD147 downstream of EGFR-pSTAT3 signaling. Here, EGFR is linked to pancreatic neoplasm.